Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

The use of combined oral contraceptive pills is completely contraindicated in patients with migraine with aura due to an increased risk of ischaemic stroke (UKMEC class 4). However, progestogen-based contraception methods and the levonorgestrel-releasing intrauterine device are considered safe (UKMEC 2) as the benefits of using these methods outweigh the potential risks. The copper intrauterine device is the only form of contraception recommended by UKMEC as having no contraindication in this condition (UKMEC 1).

Intrauterine contraceptive devices include copper IUDs and levonorgestrel-releasing IUS. Both are over 99% effective. The IUD prevents fertilization by decreasing sperm motility, while the IUS prevents endometrial proliferation and thickens cervical mucus. Potential problems include heavier periods with IUDs and initial bleeding with the IUS. There is a small risk of uterine perforation, ectopic pregnancy, and infection. New IUS systems, such as Jaydess® and Kyleena®, have smaller frames and less levonorgestrel, resulting in lower serum levels and different rates of amenorrhea.

For a newly diagnosed patient with hypertension who is under 55 years old and has stage 2 hypertension, it is recommended to add either an ACE inhibitor or an angiotensin receptor blocker. This is in accordance with the NICE guidelines, which suggest that antihypertensive drug treatments should be offered to individuals of any age with stage 2 hypertension. If the patient is 55 years or older, a calcium channel blocker like amlodipine is recommended instead.

NICE Guidelines for Managing Hypertension

Hypertension, or high blood pressure, is a common condition that can lead to serious health problems if left untreated. The National Institute for Health and Care Excellence (NICE) has published updated guidelines for the management of hypertension in 2019. Some of the key changes include lowering the threshold for treating stage 1 hypertension in patients under 80 years old, allowing the use of angiotensin receptor blockers instead of ACE inhibitors, and recommending the use of a calcium channel blocker or thiazide-like diuretic in addition to an ACE inhibitor or angiotensin receptor blocker.

The guidelines also provide a flow chart for the diagnosis and management of hypertension. Lifestyle advice, such as reducing salt intake, caffeine intake, and alcohol consumption, as well as exercising more and losing weight, should not be forgotten and is frequently tested in exams. Treatment options depend on the patient’s age, ethnicity, and other factors, and may involve a combination of drugs.

NICE recommends treating stage 1 hypertension in patients under 80 years old if they have target organ damage, established cardiovascular disease, renal disease, diabetes, or a 10-year cardiovascular risk equivalent to 10% or greater. For patients with stage 2 hypertension, drug treatment should be offered regardless of age. The guidelines also provide step-by-step treatment options, including adding a third or fourth drug if necessary.

New drugs, such as direct renin inhibitors like Aliskiren, may have a role in patients who are intolerant of more established antihypertensive drugs. However, trials have only investigated the fall in blood pressure and no mortality data is available yet. Patients who fail to respond to step 4 measures should be referred to a specialist. The guidelines also provide blood pressure targets for different age groups.

Reducing the Risk of Vascular Events: Lifestyle Interventions

Smoking, high salt intake, poor diet, lack of exercise, and obesity are all risk factors for vascular events such as heart attacks and strokes. However, making lifestyle changes can significantly reduce the risk of these events.

Stopping smoking is the most effective non-pharmacological intervention, as it reduces the risk of heart disease by 2-3 times compared to those who continue to smoke.

Reducing salt intake to 3-6 g/day can also help, as both high and low salt intake can increase the risk of vascular events.

Improving diet by controlling calorie intake can lead to weight loss, improved blood sugar control, and better lipid profiles.

Regular exercise, such as 30 minutes of activity five times a week, can lower the risk of vascular events by 30%.

Finally, weight reduction is important, as obesity increases the risk of heart attacks and strokes at a younger age and can lead to higher mortality rates.

Overall, making these lifestyle changes can significantly reduce the risk of vascular events and improve overall health.

If the patient has chronic heart failure along with atrial fibrillation, digoxin is highly recommended. However, if the patient does not have atrial fibrillation, the next step in management would be a combination of hydralazine and a nitrate like isosorbide mononitrate. While furosemide can be used for immediate fluid offloading, it does not have a positive impact on long-term outcomes.

Drug Management for Chronic Heart Failure: NICE Guidelines

Chronic heart failure is a serious condition that requires proper management to improve patient outcomes. In 2018, the National Institute for Health and Care Excellence (NICE) updated their guidelines on drug management for chronic heart failure. The guidelines recommend first-line therapy with both an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Second-line therapy involves the use of aldosterone antagonists, which should be monitored for hyperkalaemia. SGLT-2 inhibitors are also increasingly being used to manage heart failure with a reduced ejection fraction. Third-line therapy should be initiated by a specialist and may include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, or cardiac resynchronisation therapy. Other treatments such as annual influenza and one-off pneumococcal vaccines are also recommended.

Overall, the NICE guidelines provide a comprehensive approach to drug management for chronic heart failure. It is important to note that loop diuretics have not been shown to reduce mortality in the long-term, and that ACE-inhibitors and beta-blockers have no effect on mortality in heart failure with preserved ejection fraction. Healthcare professionals should carefully consider the patient’s individual needs and circumstances when determining the appropriate drug therapy for chronic heart failure.

Typical symptoms of trigeminal neuralgia are present in this woman. The initial treatment recommended for this condition is carbamazepine, which should be initiated at a dosage of 100 mg twice daily and gradually increased until pain relief is achieved.

Understanding Trigeminal Neuralgia

Trigeminal neuralgia is a type of pain syndrome that is characterized by severe pain on one side of the face. While most cases are idiopathic, some may be caused by compression of the trigeminal roots due to tumors or vascular problems. According to the International Headache Society, trigeminal neuralgia is defined as a disorder that causes brief electric shock-like pains that are limited to one or more divisions of the trigeminal nerve. The pain is often triggered by light touch, such as washing, shaving, or brushing teeth, and can occur spontaneously. Certain areas of the face, such as the nasolabial fold or chin, may be more susceptible to pain. The pain may also remit for varying periods.

Red flag symptoms and signs that suggest a serious underlying cause include sensory changes, ear problems, a history of skin or oral lesions that could spread perineurally, pain only in the ophthalmic division of the trigeminal nerve, optic neuritis, a family history of multiple sclerosis, and onset before the age of 40.

The first-line treatment for trigeminal neuralgia is carbamazepine. If there is a failure to respond to treatment or atypical features are present, such as onset before the age of 50, referral to neurology is recommended. Understanding the symptoms and management of trigeminal neuralgia is important for proper diagnosis and treatment.

The use of COCP is absolutely contraindicated for individuals who are over 35 years old and smoke more than 15 cigarettes per day. Migraine without aura is not a contraindication, but migraine with aura is a UKMEC 3 contraindication. A BMI of over 35 kg/m2 and a family history of thromboembolism at age less than 45 years are also UKMEC 3 contraindications, but in this case, the patient’s BMI is 25 kg/m2 and her mother had pulmonary embolism at the age of 60 years, so these are not contraindications. Breastfeeding less than 6 weeks post-partum is a UKMEC 4 contraindication, but since the patient is 10 weeks post-partum, it is a UKMEC 2.

The decision to prescribe the combined oral contraceptive pill is now based on the UK Medical Eligibility Criteria (UKMEC), which categorizes potential contraindications and cautions on a four-point scale. UKMEC 1 indicates no restrictions for use, while UKMEC 2 suggests that the benefits outweigh the risks. UKMEC 3 indicates that the disadvantages may outweigh the advantages, and UKMEC 4 represents an unacceptable health risk. Examples of UKMEC 3 conditions include controlled hypertension, a family history of thromboembolic disease in first-degree relatives under 45 years old, and current gallbladder disease. Examples of UKMEC 4 conditions include a history of thromboembolic disease or thrombogenic mutation, breast cancer, and uncontrolled hypertension. Diabetes mellitus diagnosed over 20 years ago is classified as UKMEC 3 or 4 depending on severity. In 2016, breast feeding between 6 weeks and 6 months postpartum was changed from UKMEC 3 to UKMEC 2.

Tardive dyskinesia can be caused by antipsychotics.

Antipsychotics are a group of drugs used to treat schizophrenia, psychosis, mania, and agitation. They are divided into two categories: typical and atypical antipsychotics. The latter were developed to address the extrapyramidal side-effects associated with the first generation of typical antipsychotics. Typical antipsychotics work by blocking dopaminergic transmission in the mesolimbic pathways through dopamine D2 receptor antagonism. They are associated with extrapyramidal side-effects and hyperprolactinaemia, which are less common with atypical antipsychotics.

Extrapyramidal side-effects (EPSEs) are common with typical antipsychotics and include Parkinsonism, acute dystonia, sustained muscle contraction, akathisia, and tardive dyskinesia. The latter is a late onset of choreoathetoid movements that may be irreversible and occur in 40% of patients. The Medicines and Healthcare products Regulatory Agency has issued specific warnings when antipsychotics are used in elderly patients, including an increased risk of stroke and venous thromboembolism. Other side-effects include antimuscarinic effects, sedation, weight gain, raised prolactin, impaired glucose tolerance, neuroleptic malignant syndrome, reduced seizure threshold, and prolonged QT interval.

Acute coronary syndrome (ACS) is a term that covers various acute presentations of ischaemic heart disease, including ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. ACS develops in patients with ischaemic heart disease, which is the gradual build-up of fatty plaques in the coronary arteries. ACS can cause chest pain, dyspnoea, sweating, and nausea and vomiting. The two most important investigations for ACS are an ECG and cardiac markers. Treatment for ACS includes preventing worsening of presentation, revascularising the vessel is occluded, and treating pain. Patients who have had an ACS require lifelong drug therapy to reduce the risk of a further event.

The use of combined oral contraceptive pill is associated with a reduced risk of endometrial cancer.

Endometrial cancer is a type of cancer that is commonly found in women who have gone through menopause, but it can also occur in around 25% of cases before menopause. The prognosis for this type of cancer is usually good due to early detection. There are several risk factors associated with endometrial cancer, including obesity, nulliparity, early menarche, late menopause, unopposed estrogen, diabetes mellitus, tamoxifen, polycystic ovarian syndrome, and hereditary non-polyposis colorectal carcinoma. Postmenopausal bleeding is the most common symptom of endometrial cancer, which is usually slight and intermittent initially before becoming more heavy. Pain is not common and typically signifies extensive disease, while vaginal discharge is unusual.

When investigating endometrial cancer, women who are 55 years or older and present with postmenopausal bleeding should be referred using the suspected cancer pathway. The first-line investigation is trans-vaginal ultrasound, which has a high negative predictive value for a normal endometrial thickness (< 4 mm). Hysteroscopy with endometrial biopsy is also commonly used for investigation. The management of localized disease involves total abdominal hysterectomy with bilateral salpingo-oophorectomy, while patients with high-risk disease may have postoperative radiotherapy. Progestogen therapy is sometimes used in frail elderly women who are not considered suitable for surgery. It is important to note that the combined oral contraceptive pill and smoking are protective against endometrial cancer.

Understanding Wernicke’s Encephalopathy

Wernicke’s encephalopathy is a condition that affects the brain and is caused by a deficiency in thiamine. This condition is commonly seen in individuals who abuse alcohol, but it can also be caused by persistent vomiting, stomach cancer, or dietary deficiencies. The classic triad of symptoms associated with Wernicke’s encephalopathy includes oculomotor dysfunction, gait ataxia, and encephalopathy. Other symptoms may include peripheral sensory neuropathy and confusion.

When left untreated, Wernicke’s encephalopathy can lead to the development of Korsakoff’s syndrome. This condition is characterized by antero- and retrograde amnesia and confabulation in addition to the symptoms associated with Wernicke’s encephalopathy.

To diagnose Wernicke’s encephalopathy, doctors may perform a variety of tests, including a decreased red cell transketolase test and an MRI. Treatment for this condition involves urgent replacement of thiamine. With prompt treatment, individuals with Wernicke’s encephalopathy can recover fully.

The tear-drop scaly papules that have suddenly appeared on the patient’s trunk and limbs suggest guttate psoriasis. This type of psoriasis is commonly seen in children and young adults who have recently had a Streptococcus infection, such as the tonsillitis infection that this patient had. The rash is characterized by multiple small scaly and red patches that have a teardrop shape.

Disseminated varicella zoster, pityriasis rosea, and pityriasis versicolor are not likely diagnoses for this patient. Disseminated varicella zoster causes a different type of rash that includes macular, papular, and vesicular lesions that crust over time. Pityriasis rosea presents with a large round herald patch on the chest, abdomen, or back, and is thought to be triggered by viral or bacterial infections. Pityriasis versicolor is a fungal infection that causes patches that are paler than the surrounding skin, and is commonly found on the upper limbs and neck. However, exposure to heat and moisture can increase the risk of developing this rash.

Guttate psoriasis is a type of psoriasis that is more commonly seen in children and adolescents. It is often triggered by a streptococcal infection that occurred 2-4 weeks prior to the appearance of the lesions. The name guttate comes from the Latin word for drop, as the lesions appear as small, tear-shaped papules on the trunk and limbs. These papules are pink and scaly, and the onset of the condition is usually acute, occurring over a few days.

In most cases, guttate psoriasis will resolve on its own within 2-3 months. There is no clear evidence to support the use of antibiotics to treat the underlying streptococcal infection. Treatment options for guttate psoriasis include topical agents commonly used for psoriasis and UVB phototherapy. In cases where the condition recurs, a tonsillectomy may be necessary.

It is important to differentiate guttate psoriasis from pityriasis rosea, another skin condition that can present with similar symptoms. Guttate psoriasis is often preceded by a streptococcal sore throat, while pityriasis rosea may be preceded by a respiratory tract infection. The appearance of guttate psoriasis is characterized by tear-shaped papules on the trunk and limbs, while pityriasis rosea presents with a herald patch followed by multiple oval lesions with a fine scale. While guttate psoriasis resolves within a few months, pityriasis rosea typically resolves after around 6 weeks.

Bedside Abdominal Ultrasound for Ruptured Abdominal Aortic Aneurysm: Diagnosis and Management

This patient is likely experiencing a ruptured abdominal aortic aneurysm (AAA), a life-threatening medical emergency. Bedside abdominal ultrasound (US) is the best initial diagnostic test for ruling out AAA as a cause of abdominal or back pain, as it provides an instant, objective measurement of aortic diameter. An AAA is a dilatation of the abdominal aorta greater than 3 cm in diameter, with a significant risk of rupture at diameters greater than 5 cm. Risk factors for AAA include smoking and co-existing vascular disease. Symptoms of a ruptured AAA include pain, cardiovascular failure, and distal ischemia. Once diagnosed, a CT angiogram is the gold-standard imaging for planning surgery to repair the aneurysm. Endoscopic retrograde cholangiopancreatography and liver function tests are not indicated in this case, while serum amylase or lipase should be measured in all patients presenting with acute abdominal or upper back pain to exclude acute pancreatitis as a differential diagnosis.

Horner’s syndrome is a medical condition that is characterized by a set of symptoms including a small pupil (miosis), drooping of the upper eyelid (ptosis), sunken eye (enophthalmos), and loss of sweating on one side of the face (anhidrosis). The presence of heterochromia, or a difference in iris color, is often seen in cases of congenital Horner’s syndrome. Anhidrosis is also a distinguishing feature that can help differentiate between central, pre-ganglionic, and post-ganglionic lesions. Pharmacologic tests, such as the use of apraclonidine drops, can be helpful in confirming the diagnosis of Horner’s syndrome and localizing the lesion.

Central lesions, pre-ganglionic lesions, and post-ganglionic lesions can all cause Horner’s syndrome, with each type of lesion presenting with different symptoms. Central lesions can result in anhidrosis of the face, arm, and trunk, while pre-ganglionic lesions can cause anhidrosis of the face only. Post-ganglionic lesions, on the other hand, do not typically result in anhidrosis.

There are many potential causes of Horner’s syndrome, including stroke, syringomyelia, multiple sclerosis, tumors, encephalitis, thyroidectomy, trauma, cervical rib, carotid artery dissection, carotid aneurysm, cavernous sinus thrombosis, and cluster headache. It is important to identify the underlying cause of Horner’s syndrome in order to determine the appropriate treatment plan.

Common Causes of Cataracts and Their Associated Symptoms

Cataracts are a common eye condition that can cause visual impairment. While ageing is the most common cause, there are several other factors that can contribute to cataract development. Here are some of the common causes of cataracts and their associated symptoms:

1. Thyrotoxicosis: This condition involves excess synthesis and secretion of thyroid hormones, leading to the hypermetabolic condition of thyrotoxicosis. Symptoms include sympathetic activation in younger patients and cardiovascular symptoms and unexplained weight loss in older patients. Approximately 50% of patients with Graves-thyrotoxicosis have mild thyroid ophthalmopathy, which can cause periorbital edema, conjunctival edema, poor lid closure, extraocular muscle dysfunction, and proptosis.

2. Diabetes mellitus: Patients with diabetes are at risk of developing several ophthalmic complications, including cataracts. Epidemiological studies have shown that cataracts are the most common cause of visual impairment in patients with older-onset diabetes. Hyperglycemia is associated with loss of lens transparency, and rapid decline of serum glucose levels in patients with marked hyperglycemia may induce temporary lens opacification and swelling.

3. Myotonic dystrophy: This chronic genetic disorder affects muscle function and can cause gradually worsening muscle atrophy and weakness. Other symptoms include cataracts, intellectual disability, and heart conduction abnormalities. Myotonic dystrophy may cause a cortical cataract with a blue dot appearance or a posterior subcapsular cataract.

4. Rubella: Congenital cataracts are usually diagnosed at birth and can be associated with ocular abnormalities, trauma, or intrauterine infection, particularly rubella. Congenital rubella infection may result in growth delay, learning disability, hearing loss, congenital heart disease, and eye, endocrinological, and neurological abnormalities.

5. Hypoparathyroidism: This condition is characterized by hypocalcemia, hyperphosphatemia, and low or inappropriately normal levels of parathyroid hormone. Patients may present with hypocalcemia, mental changes, and neuromuscular excitability or tetany. Anatomical abnormalities, although not readily apparent, include deposition of calcium in soft tissues, including intracranial calcifications and cataract formation.

In addition to these causes, cataracts can also be caused by trauma

For patients with moderate-severe depression, subthreshold depressive symptoms that have persisted for a long period, subthreshold symptoms or mild depression that persists after other interventions, or mild depression that is complicating the care of a chronic physical health problem, antidepressants are recommended. The first-line antidepressant recommended by NICE is selective serotonin reuptake inhibitors (SSRIs), such as citalopram, fluoxetine, paroxetine, and sertraline. Tricyclic antidepressants (TCAs), such as amitriptyline, should be avoided as first-line or if there is a history or likelihood of overdose due to their high toxicity in overdose.

In 2022, NICE updated its guidelines on managing depression and now classifies it as either less severe or more severe based on a patient’s PHQ-9 score. For less severe depression, NICE recommends discussing treatment options with patients and considering the least intrusive and resource-intensive treatment first. Antidepressant medication should not be routinely offered as first-line treatment unless it is the patient’s preference. Treatment options for less severe depression include guided self-help, group cognitive behavioral therapy, group behavioral activation, individual CBT or BA, group exercise, group mindfulness and meditation, interpersonal psychotherapy, SSRIs, counseling, and short-term psychodynamic psychotherapy. For more severe depression, NICE recommends a shared decision-making approach and suggests a combination of individual CBT and an antidepressant as the preferred treatment option. Other treatment options for more severe depression include individual CBT or BA, antidepressant medication, individual problem-solving, counseling, short-term psychodynamic psychotherapy, interpersonal psychotherapy, guided self-help, and group exercise.

In the case of herpes zoster ophthalmicus, topical antiviral treatment is not recommended. The first line of treatment is oral acyclovir, which should be initiated promptly and continued for 7-10 days. If there are any indications of ocular involvement, the patient should be referred to an ophthalmologist immediately. While steroids can be administered concurrently, they do not decrease the likelihood of post-herpetic neuralgia. Topical mupirocin is not an appropriate treatment option.

Herpes Zoster Ophthalmicus: Symptoms, Treatment, and Complications

Herpes zoster ophthalmicus (HZO) is a condition that occurs when the varicella-zoster virus reactivates in the area supplied by the ophthalmic division of the trigeminal nerve. It is responsible for approximately 10% of shingles cases. The main symptom of HZO is a vesicular rash around the eye, which may or may not involve the eye itself. Hutchinson’s sign, a rash on the tip or side of the nose, is a strong indicator of nasociliary involvement and increases the risk of ocular involvement.

Treatment for HZO involves oral antiviral medication for 7-10 days, ideally started within 72 hours of symptom onset. Intravenous antivirals may be necessary for severe infections or immunocompromised patients. Topical antiviral treatment is not recommended for HZO, but topical corticosteroids may be used to treat any secondary inflammation of the eye. Ocular involvement requires urgent ophthalmology review to prevent complications such as conjunctivitis, keratitis, episcleritis, anterior uveitis, ptosis, and post-herpetic neuralgia.

In summary, HZO is a condition caused by the reactivation of the varicella-zoster virus in the ophthalmic division of the trigeminal nerve. It presents with a vesicular rash around the eye and may involve the eye itself. Treatment involves oral antiviral medication and urgent ophthalmology review is necessary for ocular involvement. Complications of HZO include various eye conditions, ptosis, and post-herpetic neuralgia.

Liver Disorders in Pregnancy: Differential Diagnosis

During pregnancy, various liver disorders can occur, each with its own set of symptoms and potential complications. Here are some of the most common liver disorders that can occur during pregnancy and their distinguishing features:

1. Hyperemesis gravidarum: This is the most severe form of nausea and vomiting in pregnancy, which can lead to weight loss, dehydration, and electrolyte imbalances. It is characterised by persistent nausea and vomiting, and may require hospitalisation.

2. Acute fatty liver of pregnancy: This is a rare but serious complication that can occur in the third trimester. It is characterised by microvesicular steatosis in the liver, which can lead to liver insufficiency. Symptoms include malaise, nausea and vomiting, right upper quadrant and epigastric pain, and acute renal failure.

3. Intrahepatic cholestasis of pregnancy: This is the most common pregnancy-related liver disorder, characterised by generalised itching, particularly in the palms and soles, and jaundice. It is caused by hormonal changes and can lead to fetal complications if not treated promptly.

4. Pre-eclampsia: This is a disorder of widespread vascular malfunction that occurs after 20 weeks of gestation. It is characterised by hypertension and proteinuria, with or without oedema.

5. Biliary tract disease: This is a broad spectrum of disorders ranging from asymptomatic gallstones to cholecystitis and choledocholithiasis. Symptoms include biliary colic, inflammation of the gall bladder wall, and obstruction of the common bile duct.

It is important to differentiate between these liver disorders in pregnancy, as each requires a different approach to management and treatment. Consultation with a healthcare provider is recommended for proper diagnosis and management.

Anastrozole, an aromatase inhibitor, is a recommended adjuvant therapy for patients with oestrogen positive cancer (ER+). However, it may lead to osteoporosis as an adverse effect. Therefore, NICE recommends performing a DEXA scan before initiating therapy. A clotting screen is not necessary before starting anastrozole, as it does not cause coagulopathies. ECGs are not required either, as cardiac changes and arrhythmias are not associated with this medication. Unlike certain medications like statins, anastrozole is not known to commonly affect lipid profiles, so it does not need to be monitored. Liver function tests are also not routinely assessed before starting anastrozole, as it is not known to affect liver function. However, it would have been appropriate to send a clotting screen before the patient’s lumpectomy.

Anti-oestrogen drugs are used in the management of oestrogen receptor-positive breast cancer. Selective oEstrogen Receptor Modulators (SERM) such as Tamoxifen act as an oestrogen receptor antagonist and partial agonist. However, Tamoxifen can cause adverse effects such as menstrual disturbance, hot flushes, venous thromboembolism, and endometrial cancer. On the other hand, aromatase inhibitors like Anastrozole and Letrozole reduce peripheral oestrogen synthesis, which is important in postmenopausal women. Anastrozole is used for ER +ve breast cancer in this group. However, aromatase inhibitors can cause adverse effects such as osteoporosis, hot flushes, arthralgia, myalgia, and insomnia. NICE recommends a DEXA scan when initiating a patient on aromatase inhibitors for breast cancer.

Regardless of age, ACE inhibitors/A2RBs are the first-line treatment for hypertension in diabetics.

Blood Pressure Management in Diabetes Mellitus

Patients with diabetes mellitus have traditionally been managed with lower blood pressure targets to reduce their overall cardiovascular risk. However, a 2013 Cochrane review found that there was little difference in outcomes between patients who had tight blood pressure control (targets < 130/85 mmHg) and those with more relaxed control (< 140-160/90-100 mmHg), except for a slightly reduced rate of stroke in the former group. As a result, NICE recommends a blood pressure target of < 140/90 mmHg for type 2 diabetics, the same as for patients without diabetes. For patients with type 1 diabetes, NICE recommends a blood pressure target of 135/85 mmHg unless they have albuminuria or two or more features of metabolic syndrome, in which case the target should be 130/80 mmHg. ACE inhibitors or angiotensin-II receptor antagonists (A2RBs) are the first-line antihypertensive regardless of age, as they have a renoprotective effect in diabetes. A2RBs are preferred for black African or African-Caribbean diabetic patients. Further management then follows that of non-diabetic patients. It is important to note that autonomic neuropathy may result in more postural symptoms in patients taking antihypertensive therapy. Therefore, the routine use of beta-blockers in uncomplicated hypertension should be avoided, particularly when given in combination with thiazides, as they may cause insulin resistance, impair insulin secretion, and alter the autonomic response to hypoglycemia.

The most common cause of small bowel obstruction is adhesions. This patient is experiencing symptoms such as abdominal pain, distention, and constipation, which are similar to those of large bowel obstruction. However, the onset of nausea and vomiting is an early sign of small bowel obstruction, indicating a proximal lesion. Adhesions are scar tissue that can form due to inflammation or manipulation of the abdominal contents during surgery, and they are often present in patients who are asymptomatic for years before experiencing symptoms. Given the patient’s history of a previous cesarean section, adhesional small bowel obstruction is a likely diagnosis.

Large bowel obstruction is most commonly caused by colorectal cancer, and symptoms include abdominal pain, distention, and constipation. However, nausea and vomiting are later signs compared to small bowel obstruction.

Gallstone ileus is a rare complication of cholecystitis where a gallstone passes through a fistula between the gallstone and small bowel before becoming impacted, leading to small bowel obstruction.

Inguinal hernias can also cause small bowel obstruction, as they involve a protrusion of abdominal contents through a defect in the abdominal wall. However, the patient’s history of previous abdominal surgery makes adhesions a more likely cause.

While regular opioid use can lead to constipation, it is not a cause of obstruction. In this case, the patient’s bilious vomiting and positive findings of abdominal tenderness and distension suggest intestinal obstruction rather than simple constipation.

Small bowel obstruction occurs when the small intestines are blocked, preventing the passage of food, fluids, and gas. The most common cause of this condition is adhesions, which can develop after previous surgeries, followed by hernias. Symptoms of small bowel obstruction include diffuse, central abdominal pain, nausea and vomiting (often bilious), constipation, and abdominal distension. Tinkling bowel sounds may also be present in early stages of obstruction. Abdominal x-ray is typically the first-line imaging for suspected small bowel obstruction, showing distended small bowel loops with fluid levels. CT is more sensitive and considered the definitive investigation, particularly in early obstruction. Management involves initial steps such as NBM, IV fluids, and nasogastric tube with free drainage. Some patients may respond to conservative management, but others may require surgery.

Heart failure is a complete contraindication for the use of pioglitazone and other thiazolidinediones.

Thiazolidinediones: A Class of Diabetes Medications

Thiazolidinediones are a type of medication used to treat type 2 diabetes. They work by activating the PPAR-gamma receptor, which reduces insulin resistance in the body. However, one medication in this class, rosiglitazone, was withdrawn in 2010 due to concerns about its cardiovascular side effects.

The PPAR-gamma receptor is a nuclear receptor found inside cells. It is naturally activated by free fatty acids and is involved in regulating the differentiation and function of adipocytes (fat cells).

While thiazolidinediones can be effective in treating diabetes, they can also have adverse effects. Patients may experience weight gain, liver impairment (which requires monitoring of liver function tests), and fluid retention. Thiazolidinediones are contraindicated in patients with heart failure due to the increased risk of fluid retention, especially if the patient is also taking insulin. Recent studies have also shown an increased risk of fractures and bladder cancer in patients taking pioglitazone, another medication in this class.

Pancreatic cancer is best diagnosed through high-resolution CT scanning. Although chronic pancreatitis increases the risk, neither alcohol nor gallstone disease are significant independent risk factors. Radiotherapy is not effective for surgical resection. Unfortunately, most patients are diagnosed with unresectable lesions.

Understanding Pancreatic Cancer: Risk Factors, Symptoms, and Management

Pancreatic cancer is a type of cancer that is often diagnosed late due to its non-specific symptoms. Adenocarcinomas, which occur at the head of the pancreas, make up over 80% of pancreatic tumors. Risk factors for pancreatic cancer include increasing age, smoking, diabetes, chronic pancreatitis, hereditary non-polyposis colorectal carcinoma, and genetic mutations such as BRCA2 and KRAS.

Symptoms of pancreatic cancer can include painless jaundice, pale stools, dark urine, pruritus, anorexia, weight loss, epigastric pain, loss of exocrine and endocrine function, and atypical back pain. Migratory thrombophlebitis, also known as Trousseau sign, is more common in pancreatic cancer than in other cancers.

Diagnosis of pancreatic cancer can be made through ultrasound or high-resolution CT scanning, which may show the double duct sign – simultaneous dilatation of the common bile and pancreatic ducts. However, less than 20% of patients are suitable for surgery at diagnosis. A Whipple’s resection, or pancreaticoduodenectomy, may be performed for resectable lesions in the head of the pancreas. Adjuvant chemotherapy is usually given following surgery, and ERCP with stenting may be used for palliation.

In summary, pancreatic cancer is a serious disease with non-specific symptoms that can be difficult to diagnose. Understanding the risk factors and symptoms can help with early detection and management.

The management of asthma in adults has been updated by NICE in 2017, following the 2016 BTS guidelines. One of the significant changes is in ‘step 3’, where patients on a SABA + ICS whose asthma is not well controlled should be offered a leukotriene receptor antagonist instead of a LABA. NICE does not follow the stepwise approach of the previous BTS guidelines, but to make the guidelines easier to follow, we have added our own steps. The steps range from newly-diagnosed asthma to SABA +/- LTRA + one of the following options, including increasing ICS to high-dose, a trial of an additional drug, or seeking advice from a healthcare professional with expertise in asthma. Maintenance and reliever therapy (MART) is a form of combined ICS and LABA treatment that is only available for ICS and LABA combinations in which the LABA has a fast-acting component. It should be noted that NICE does not recommend changing treatment in patients who have well-controlled asthma simply to adhere to the latest guidance. The definitions of what constitutes a low, moderate, or high-dose ICS have also changed, with <= 400 micrograms budesonide or equivalent being a low dose, 400 micrograms - 800 micrograms budesonide or equivalent being a moderate dose, and > 800 micrograms budesonide or equivalent being a high dose for adults.

The typical blood picture for DIC includes a decrease in platelets and fibrinogen levels, as well as an increase in PT and APTT, and fibrinogen degradation products. DIC can be triggered by trauma, malignancies, and other factors. The patient’s symptoms, such as oliguria, hypotension, and tachycardia, suggest circulatory collapse due to DIC. Bleeding at multiple sites, including haematuria, petechial bruising, and bleeding from a peripheral cannula, is also common in DIC. The release of procoagulants in DIC leads to widespread clotting activation, which consumes platelets and clotting factors, resulting in a low platelet count and prolonged bleeding times. Fibrinolysis is also activated, leading to low fibrinogen levels and high D-dimer levels. Additionally, haemoglobin levels may be low due to bleeding and lysis caused by fibrin strands in small blood vessels.

Understanding Disseminated Intravascular Coagulation (DIC) Diagnosis

Under normal conditions, coagulation and fibrinolysis work together to maintain homeostasis. However, in DIC, these processes become dysregulated, leading to widespread clotting and bleeding. One key factor in the development of DIC is the release of tissue factor (TF), a glycoprotein found on the surface of various cell types. Normally, TF is not in contact with the general circulation, but it is exposed after vascular damage or in response to certain cytokines. Once activated, TF triggers the extrinsic pathway of coagulation, which then triggers the intrinsic pathway. DIC can be caused by various factors, including sepsis, trauma, obstetric complications, and malignancy.

To diagnose DIC, a typical blood picture will show decreased platelets and fibrinogen, increased fibrinogen degradation products, and the presence of schistocytes due to microangiopathic hemolytic anemia. Additionally, both the prothrombin time and activated partial thromboplastin time are prolonged, while bleeding time and platelet count are often low. Understanding the diagnosis of DIC is crucial for prompt and effective treatment.

The symptoms of HELLP syndrome, a severe form of pre-eclampsia, include haemolysis (H), elevated liver enzymes (EL), and low platelets (LP). A patient with this condition may experience malaise, nausea, vomiting, and headache, as well as hypertension with proteinuria and epigastric and/or upper abdominal pain. The patient in this case meets the requirements for a diagnosis of HELLP syndrome.

Liver Complications During Pregnancy

During pregnancy, there are several liver complications that may arise. One of the most common is intrahepatic cholestasis of pregnancy, which occurs in about 1% of pregnancies and is typically seen in the third trimester. Symptoms include intense itching, especially in the palms and soles, as well as elevated bilirubin levels. Treatment involves the use of ursodeoxycholic acid for relief and weekly liver function tests. Women with this condition are usually induced at 37 weeks to prevent stillbirth, although maternal morbidity is not typically increased.

Another rare complication is acute fatty liver of pregnancy, which may occur in the third trimester or immediately after delivery. Symptoms include abdominal pain, nausea and vomiting, headache, jaundice, and hypoglycemia. Severe cases may result in pre-eclampsia. ALT levels are typically elevated, and support care is the primary management until delivery can be performed once the patient is stabilized.

Finally, conditions such as Gilbert’s and Dubin-Johnson syndrome may be exacerbated during pregnancy. Additionally, HELLP syndrome, which stands for haemolysis, elevated liver enzymes, and low platelets, is a serious complication that can occur in the third trimester and requires immediate medical attention. Overall, it is important for pregnant women to be aware of these potential liver complications and to seek medical attention if any symptoms arise.

The woman’s symptoms are most likely caused by the intrauterine device (IUD), which is known to increase the intensity and discomfort of periods. Ectopic pregnancy and miscarriage are unlikely as the pregnancy test was negative. A urinary tract infection is also unlikely as the urine dip was normal. Although appendicitis should be considered, it does not explain the vaginal bleeding, and the woman’s normal appetite, lack of fever, and mild examination results do not support this diagnosis.

Intrauterine contraceptive devices include copper IUDs and levonorgestrel-releasing IUS. Both are over 99% effective. The IUD prevents fertilization by decreasing sperm motility, while the IUS prevents endometrial proliferation and thickens cervical mucus. Potential problems include heavier periods with IUDs and initial bleeding with the IUS. There is a small risk of uterine perforation, ectopic pregnancy, and infection. New IUS systems, such as Jaydess® and Kyleena®, have smaller frames and less levonorgestrel, resulting in lower serum levels and different rates of amenorrhea.

Malaria Chemoprophylaxis: Choosing the Right Medication

Malaria is a potentially fatal disease that requires chemoprophylaxis for individuals entering known malaria areas. Atovaquone/proguanil (Malarone) is a well-tolerated, once-daily medication that is effective in both preventing and treating malaria. It should be taken 24 hours before entering a malaria zone and continued for seven days after leaving. However, advice on bite avoidance is also crucial in preventing malaria.

Doxycycline is a cheaper alternative to atovaquone/proguanil, but it may cause nausea and photosensitivity, which can be problematic for fair-skinned individuals. Chloroquine is an inferior choice due to widespread resistance, while mefloquine (Larium) may cause psychosis, making it unsuitable for patients with a psychiatric history.

It is important to note that advising against chemoprophylaxis is not appropriate, as malaria poses a serious risk to all individuals, regardless of their previous exposure to malaria areas.

The symphysis-fundal height in centimeters after 20 weeks of gestation is equal to the number of weeks of gestation.

The symphysis-fundal height (SFH) is a measurement taken from the pubic bone to the top of the uterus in centimetres. It is used to determine the gestational age of a fetus and should match within 2 cm after 20 weeks. For example, if a woman is 24 weeks pregnant, a normal SFH would be between 22 and 26 cm. Proper measurement of SFH is important for monitoring fetal growth and development during pregnancy.

Quinine is the only medication in this list that is strongly linked to the development of drug-induced thrombocytopaenia. However, excessive consumption of tonic water containing quinine can also lead to this condition in certain individuals. While all the other medications in the list can be used to treat nocturnal leg cramps, they do not have a significant association with thrombocytopaenia.

Understanding Drug-Induced Thrombocytopenia

Drug-induced thrombocytopenia is a condition where a person’s platelet count drops due to the use of certain medications. This type of thrombocytopenia is believed to be immune-mediated, meaning that the body’s immune system mistakenly attacks and destroys platelets. Some of the drugs that can cause this condition include quinine, abciximab, NSAIDs, diuretics like furosemide, antibiotics such as penicillins, sulphonamides, and rifampicin, anticonvulsants like carbamazepine and valproate, and heparin.

It is important to note that not everyone who takes these medications will develop drug-induced thrombocytopenia. However, those who do may experience symptoms such as easy bruising, bleeding gums, nosebleeds, and prolonged bleeding from cuts. In severe cases, the condition can lead to life-threatening bleeding.